Center for Hypertrophic Cardiomyopathy and Valvular Cardiopathies, Monza Hospital, Monza, Italy.
Medical Genetics Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy.
JAMA Cardiol. 2017 Oct 1;2(10):1147-1151. doi: 10.1001/jamacardio.2017.2353.
Diagnostic screening for Anderson-Fabry cardiomyopathy (AFC) is performed in the presence of specific clinical red flags in patients with hypertrophic cardiomyopathy (HCM) older than 25 years. However, left ventricular outflow tract obstruction (LVOTO) has been traditionally considered an exclusion criteria for AFC.
To examine a series of patients diagnosed with HCM and severe basal LVOTO undergoing myectomy in whom the diagnosis of AFC was suspected by the cardiac surgeon intraoperatively and confirmed by histological and genetic examinations.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective analysis of patients undergoing surgical septal reduction strategies was conducted in 3 European tertiary referral centers for HCM from July 2013 to December 2016. Patients with a clinical diagnosis of obstructive HCM referred for surgical management of LVOTO were observed for at least 18 months after the procedure (mean [SD] follow-up, 33 [14] months).
Etiology of patients with HCM who underwent surgical myectomy.
From 2013, 235 consecutive patients with a clinical diagnosis of HCM underwent septal myectomy. The cardiac surgeon suspected a storage disease in 3 patients (1.3%) while inspecting their heart samples extracted from myectomy. The mean (SD) age at diagnosis for these 3 patients was 42 (4) years; all were male. None of the 3 patients presented with extracardiac features suggestive of AFC. All patients showed asymmetrical left ventricular hypertrophy, with maximal left ventricular thickness in the basal septum (19-31 mm), severe basal LVOTO (70-120 mm Hg), and left atrial dilatation (44-57 mm). Only 1 patient presented with late gadolinium enhancement on cardiovascular magnetic resonance at the right ventricle insertion site. The mean (SD) age at surgical procedure was 63 (5) years. On tactile sensation, the surgeon felt a spongy consistency of the surgical samples, different from the usual stony-elastic consistency typical of classic HCM, and this prompted histological examinations. Histology showed evidence of intracellular storage, and genetic analysis confirmed a GLA A gene mutation (p.Asn215Ser) in all 3 patients.
Screening for AFC should be performed even in the absence of red flags in patients with HCM older than 25 years.
在年龄大于 25 岁的肥厚型心肌病(HCM)患者中,若存在特定的临床特征,则会进行安德森-法布里心肌病(AFC)的诊断性筛查。然而,左心室流出道梗阻(LVOTO)传统上被认为是 AFC 的排除标准。
研究一组被诊断为 HCM 且存在严重基底段 LVOTO 的患者,这些患者在接受心脏外科医生手术时,因怀疑存在 AFC 而被诊断,随后通过组织学和遗传学检查得到证实。
设计、地点和参与者:这项回顾性分析是在 2013 年 7 月至 2016 年 12 月期间,在欧洲的 3 个 HCM 三级转诊中心进行的,涉及接受手术间隔减压策略的患者。对临床诊断为梗阻性 HCM 并接受 LVOTO 手术治疗的患者进行观察,至少在术后 18 个月(平均[SD]随访时间,33[14]个月)。
行心脏外科手术的 HCM 患者的病因。
从 2013 年开始,235 例有临床诊断的 HCM 患者接受了心脏外科手术。3 名(1.3%)患者在检查心脏外科医生从心脏外科手术中取出的心脏样本时,怀疑存在贮存疾病。这 3 名患者的诊断年龄分别为 42(4)岁、均为男性,均无提示 AFC 的心脏外特征。所有患者均表现为非对称性左心室肥厚,左心室基底部室间隔最厚(19-31mm),严重的基底段 LVOTO(70-120mmHg)和左心房扩张(44-57mm)。仅 1 例患者在右心室插入部位的心血管磁共振上显示延迟钆增强。患者的手术年龄平均(SD)为 63(5)岁。在触诊时,外科医生感觉到手术样本具有海绵状的质地,与典型的经典 HCM 的通常的石样弹性质地不同,这促使进行组织学检查。组织学检查显示存在细胞内贮存的证据,且基因分析在这 3 名患者中均证实存在 GLA A 基因突变(p.Asn215Ser)。
即使年龄大于 25 岁的 HCM 患者无临床特征,也应进行 AFC 的筛查。